Free Cash Flow Build Up

Cassava Sciences Inc

Cassava Sciences Inc (SAVA)

$10.57
0.09 (+0.86%)
Year
A/P
2013
Actual
2014
Projected
2015
Projected
2016
Projected
2017
Projected
2018
Projected
2019
Projected
2020
Projected
2021
Projected
2022
Projected
2023
Projected
2024
Projected
Revenue 41.12-----------
EBITDA 31.37-----------
EBIT ------------
Tax Rate -0.23%0.00%0.00%0.00%0.00%0.00%0.00%-0.03%-0.03%-0.03%-0.03%-0.03%
EBIAT ------------
Depreciation ------------
Accounts Receivable ------------
Inventories ------------
Accounts Payable ------------
Capital Expenditure --0.08-0.20-0.07---0.02-----
UFCF ------------
WACC
PV UFCF -----------
SUM PV UFCF -